Ticker: ZBIO

Zenas BioPharma, Inc. (NASDAQ: ZBIO) - quick read on what's happening inside The company is executing an expensive, accelerated clinical and pre-commercial build for its lead drug obexelimab while monetizing regional rights (Zai, Tenacia, BMS). Cash and liquid securities are healthy today, but bu...